Firelli Alonso-Caplen

Title: Firelli Alonso-Caplen: Innovator in Respiratory Syncytial Virus Research

Introduction

Firelli Alonso-Caplen is a notable inventor based in Tappan, NY (US). He has made significant contributions to the field of virology, particularly in the study of respiratory syncytial virus (RSV). His innovative work has led to advancements in the production of viral glycoproteins, which are crucial for developing immunogenic compositions.

Latest Patents

Alonso-Caplen holds a patent for a process aimed at increasing RSV surface glycoprotein yields using a mutant strain of RSV. This process, titled "Process for increasing RSV surface glycoprotein yields using a mutant strain of RSV," results in a remarkable five-fold increase in the yields of fusion (F) and attachment (G) glycoproteins when compared to the parent A2 strain. The immunogenic compositions derived from this process can be formulated for in vivo administration, providing protection against diseases caused by RSV.

Career Highlights

Firelli Alonso-Caplen is associated with Wyeth Holdings Corporation, where he has been instrumental in advancing research related to RSV. His work has not only contributed to scientific knowledge but also has practical implications for vaccine development and disease prevention.

Collaborations

Throughout his career, Alonso-Caplen has collaborated with esteemed colleagues, including Robert Repetto and Earl Joseph Pursell. These collaborations have fostered a productive research environment, leading to significant advancements in their field.

Conclusion

Firelli Alonso-Caplen's innovative contributions to RSV research exemplify the impact of dedicated inventors in the scientific community. His patented process for enhancing glycoprotein yields represents a significant step forward in the fight against respiratory diseases.